Article citationsMore>>

Margolis, J., McDonald, J., Heuser, R., Klinke, P., Waksman, R., Virmani, R., et al. (2007) Systemic Nanoparticle Paclitaxel (Nab-Paclitaxel) for In-Stent Restenosis I (SNAPIST-I): A First-in-Human Safety and Dose-Finding Study. Clinical Cardiology, 30, 165-170.
http://dx.doi.org/10.1002/clc.20066

has been cited by the following article:

• TITLE: Nanomedicine: Tiny Particles and Machines, from Diagnosis to Treatment of Cardiovascular Disease, Provides Huge Achievements

  AUTHORS: Md. Ismail, Md. Faruk Hossain, Md. Fazlul Karim, Hossain Uddin Shekhar

  KEYWORDS: Nanomedicine, Cardiovascular Disease, Diagnosis, Treatment

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.6 No.9, September 24, 2015

  ABSTRACT: Cardiovascular disease is one of many reverberating ailments that affect and kill hundreds of thousands of people around the world. To date treatments that offer improvement in the health condition of diseased people include the most promising nanomedicine although it is in its infancy, yet attaining attention from researchers of top notch day by day. In this current review importance is given on the application of nanomedicine in the diagnosis as well as treatment of cardiovascular disease.